A
AbbVie
AbbVie Ventures
Ace Vision Group
Acuta Capital Partners
Adaptive Sensory Technology
Advanced Vision Care Ophthalmology
AesculaTech
Afecta
AiViva BioPharma
AivoCode
Alimera Sciences
Allgenesis Biotherapeutics
Annexin Pharmaceuticals
Annexon Biosciences
Apellis Pharmaceuticals
Aramis Biosciences
Ascidian Therapeutics
AsclepiX Therapeutics
Ashvattha Therapeutics
Aurion Biotech
B
Bausch + Lomb
Belite Bio
Blink
BofA Securities | Life Sciences
Bowden Eye & Associates
C
Canyon City Eyecare
California Institute for Regenerative
Medicine (CIRM)
Centricity Vision
Canyon City Eyecare
Character Biosciences
Clindepth Science Consulting
CrownPoint Medical
D
Decheng Capital
Deep Track Capital
Diorasis Therapeutics
Dompe Pharmaceuticals
Drake Precision Optics
Dunlap Ophthalmology Consulting
E
elCON Enterprises
Elios Vision
Eluminex Biosciences
Ethis Communications
Euclid Vision Group
Evoq Technologies
Exonate
ExSight Ventures
Eye Center Prof. Holzer & Prof. Rabsilber
Eyedaptic
Eyedetec Medical
Eyegenex
EYE-Go
EyeLight Innovations
Eyenovia
EyePoint Pharmaceuticals
EyeSonix
F
FELIQS
Flying L Partners
ForwardVue Pharma
Foundation Fighting Blindness
G
Glaucoma Consultants of Long Island
Glaucoma Institute of Beverly Hills
Research Foundation
Glaukos
Glint Pharmaceuticals
H
Harrow
Horizon Surgical Systems
HSBC Innovation Banking
I
IACTA Pharaceuticals
Illinois Eye and Ear Infirmary
Implandata Ophthalmic Products
InflammX Therapeutics
InFocus Capital Partners
InGel Therapeutics
Ingenia Therapeutics
Intergalactic Therapeutics
Intrepid Eye Society
Intuitive Ventures
Iolyx
iuvo BioScience
iVeena Delivery Systems
Iveric Bio
J
J&J Innovative Medicine
John A. Moran Eye Center, University of Utah
Johnson & Johnson Vision
K
Kentucky College of Optometry
Kentucky Eye Institute
Kiora Pharmaceuticals
L
Lexitas Pharma
Lifecore Biomedical
Link Consulting
Lubris BioPharma
M
MacuMira Medical Devices
MediPrint Ophthalmics
Metis Consulting Services
MingSight Pharmaceuticals
m-lab GmbH
Myra Vision
N
Nanoscope Therapeutics
Needham
Neuroptika
Neurotech Pharmaceuticals
New York Eye and Ear Infirmary
of Mount Sinai
Nichibei Advisors
Novai
NVision Clinical Research
O
OASIS Medical
OCLI Vision
Ocudyne
Ocular Therapeutix
Oculis
Ocuphire Pharma
OcuTerra Therapeutics
OD-OS GmbH
ONL Therapeutics
Optigo Biotherapeutics
Opus Genetics
Ora
Osanni Bio
P
Palatin Technologies
Perfuse Therapeutics
PerZeption
Pivotal bioVenture Partners
Platanus Ventures
Powered Research
Powers & Company
Q
Qlaris Bio
R
Ray Therapeutics
Raymond James
Rayner
REGENXBIO Remiges Ventures
Retina Vitreous Associates Medical Group
RetinAI Medical AG
Re-Vana Therapeutics
Review of Optometry
Rezolute Bio
Ripple Therapeutics
S
S-Alpha Therapeutics USA
Santen
Santen Ventures
SB Strategic Development Consultants
Seinda Biomedical
Senju Pharmaceutical
Senju USA
Shiley Eye Institute
Siloam Eye Hospital
Skye Bioscience
Southern California Eye Institute
Spherix Global Insights
Steadfast Design Firm
Stealth BioTherapeutics
Stein Eye Institute at UCLA
Stifel Financial
Strategic Intelligence
Stuart Therapeutics
Surface Ophthalmics
Sydnexis
T
Tarsier Pharma
Tarsus Pharmaceuticals
TFS CRO
The Colorado Retina Center
The Mount Sinai Hospital
Théa Open Innovation
TherOptix
TMV Associates
Topcon Healthcare
Topcon Medical Systems
Topcon Ventures
Toray Industries America
Trefoil Therapeutics
Treggar Solutions
Trial Runners
Trukera Medical
TTP plc
Two Labs
U
United Medical Research Institute
University of California San Francisco School of Medicine
University of Colorado School of Medicine
V
Vantage Biosciences
Vial
ViaLase
Viatris
Visant Medical
Visionary Executive Search
Visionary Eye Institute
Visionary Venture Fund
Visus Therapeutics
Vyluma
W
Warrenville EyeCare & LASIK
Worldwide Clinical Trials
Y
Y Factor Consulting
#
20/20 OptimEyes Technologies